...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

Dear Agoracom Family,

I want to thank all of you for your patience with us over the past 48 hours and apologize for what was admittedly a botched launch of our new site.

As you can see, we have reverted back to the previous version of the site while we address multiple forum functionality flaws that inexplicably made their way into the launch.

To this end:

1.We have identified 8 fundamental but easily fixable flaws that will be corrected in the coming week, so that you can continue to use the forums exactly as you've been accustomed to.

2.Additionally we will also be implementing a couple of design improvements to "tighten up" the look and feel of the forums.

Sincerely,

George et al

Message: Win or lose....one thing we know for sure
Reply New Message
Prev Message Back To Forum Threaded View Next Message

 Bear this has bothered me since the very beginning. I always wondered why the company was “forced” to include  atorvastatin in their study. The FDA/EMA requiring this sub group to be part of the trial is equivalent to someone’s mother insisting they take their kid brother to the party with them (only with much greater potential for an undesirable outcome). I agree that this could make a significant difference in the end result of the trial. 

Nike: Our company wants to run a study on how high athletes can jump while wearing these new shoes we designed.

Marketing Group: Okay, but half the participants must be paralympic athletes, because it would be unfair not  to include them. 

DND

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply